The company will spin off the Bausch + Lomb Brand into a fully integrated, pure play eye-health company, and incorporate its other eye health product offerings into the new company.
Bausch Health will then focus on its gastroenterology, aesthetics/dermatology, neurology and pharmaceuticals businesses.
Company leadership said it wanted to spin the company off to “better enable stakeholders to value each business independently.”
More articles on specialty centers:
ASC considers in-house alternative to ‘overwhelmed’ hospital testing center — 3 insights
425 surgery centers that received PPP funds of more than $150K by state
4 COVID-19 testing insights for ASCs
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
